Elena Rivero-Ferrer

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Cross Sectional

Clinical Practice

Top Venues

International journal of chronic obstructive pulmonary disease

Clinical drug investigation

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, David Martinez, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
Risk Assessment of Acute Myocardial Infarction and Stroke Associated with Long-Acting Muscarinic Antagonists, Alone or in Combination, versus Long-Acting beta2-Agonists. International journal of chronic obstructive pulmonary disease 17 (2022)
Elena Rivero-Ferrer, Morten Olesen, Estel Plana, Jaume Aguado, Nuria Saigi-Morgui, Annalisa Rubino, Sami Z Daoud, Alejhandra Lei, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Jesper Hallas, Cristina Rebordosa, Cristina Rebordosa
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany. Clinical drug investigation 42 (4) (2022)
Andrea V Margulis, Alison Tse Kawai, Mary S Anthony, Elena Rivero-Ferrer
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications? Pharmacoepidemiology and drug safety (2021)
Cristina Rebordosa, Estel Plana, Annalisa Rubino, Jaume Aguado, Alejhandra Lei, Sami Daoud, Nuria Saigi-Morgui, Susanna Perez-Gutthann, Elena Rivero-Ferrer
A Cohort Study to Evaluate the Risk of Hospitalisation for Congestive Heart Failure Associated with the Use of Aclidinium and Other Chronic Obstructive Pulmonary Disease Medications in the UK Clinical Practice Research Datalink. International journal of chronic obstructive pulmonary disease 16 (2021)